BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun C, Rosendahl AH, Ansari D, Andersson R. Proteome-based biomarkers in pancreatic cancer. World J Gastroenterol 2011; 17(44): 4845-4852 [PMID: 22171124 DOI: 10.3748/wjg.v17.i44.4845]
URL: https://www.wjgnet.com/1007-9327/full/v17/i44/4845.htm
Number Citing Articles
1
Meritxell Balmaña, Adrià Duran, Catarina Gomes, Esther Llop, Raquel López-Martos, M. Rosa Ortiz, Sílvia Barrabés, Celso A. Reis, Rosa Peracaula. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissuesInternational Journal of Biological Macromolecules 2018; 112: 33 doi: 10.1016/j.ijbiomac.2018.01.148
2
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteome alterations in pancreatic ductal adenocarcinomaCancer Letters 2020; 469: 429 doi: 10.1016/j.canlet.2019.11.020
3
Ulf Landegren, Maria Hammond. Cancer diagnostics based on plasma protein biomarkers: hard times but great expectationsMolecular Oncology 2021; 15(6): 1715 doi: 10.1002/1878-0261.12809
4
Steven Haenen, Elke Clynen, Benoit Nemery, Peter H.M. Hoet, Jeroen A.J. Vanoirbeek. Biomarker discovery in asthma and COPD: Application of proteomics techniques in human and miceEuPA Open Proteomics 2014; 4: 101 doi: 10.1016/j.euprot.2014.04.008
5
Hui-Lin Ye, Dou-Dou Li, Qing Lin, Yu Zhou, Quan-Bo Zhou, Bing Zeng, Zhi-Qiang Fu, Wen-Chao Gao, Yi-Min Liu, Rui-Wan Chen, Zhi-Hua Li, Ru-Fu Chen. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survivalWorld Journal of Gastroenterology 2015; 21(21): 6621-6630 doi: 10.3748/wjg.v21.i21.6621
6
Umashankar K. Ballehaninna, Ronald S. Chamberlain. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9Tumor Biology 2013; 34(6): 3279 doi: 10.1007/s13277-013-1033-3
7
Claire Jenkinson, Julie Earl, Paula Ghaneh, Christopher Halloran, Alfredo Carrato, William Greenhalf, John Neoptolemos, Eithne Costello. Biomarkers for early diagnosis of pancreatic cancerExpert Review of Gastroenterology & Hepatology 2015; 9(3): 305 doi: 10.1586/17474124.2015.965145
8
一 张. Advances in Circulating Biomarkers of Pancreatic CancerAdvances in Clinical Medicine 2021; 11(05): 2055 doi: 10.12677/ACM.2021.115294
9
Ruchika Bhawal, Ann L. Oberg, Sheng Zhang, Manish Kohli. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in CancerCancers 2020; 12(9): 2428 doi: 10.3390/cancers12092428
10
Christina Loosse, Katrin Marcus, Bodo Schoenebeck. The CytoskeletonNeuromethods 2013; 79: 85 doi: 10.1007/978-1-62703-266-7_5
11
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in ProteomicsCancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
12
John A. Williams. Proteomics as a Systems Approach to PancreatitisPancreas 2013; 42(6): 905 doi: 10.1097/MPA.0b013e31828fddc3
13
R Roy, D Zurakowski, J Wischhusen, C Frauenhoffer, S Hooshmand, M Kulke, M A Moses. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignanciesBritish Journal of Cancer 2014; 111(9): 1772 doi: 10.1038/bjc.2014.462
14
Sheng Pan, Teresa A. Brentnall, Kimberly Kelly, Ru Chen. Tissue proteomics in pancreatic cancer study: Discovery, emerging technologies, and challengesPROTEOMICS 2013; 13(3-4): 710 doi: 10.1002/pmic.201200319
15
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, Kai Zheng, Shouxia Xie, Xiao Wang. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon CancerBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/6107865
16
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteomics analysis of bodily fluids in pancreatic cancerPROTEOMICS 2015; 15(15): 2705 doi: 10.1002/pmic.201400476
17
Nalin C. W. Goonesekere, Xiaosheng Wang, Lindsey Ludwig, Chittibabu Guda, Jörg D. Hoheisel. A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and BiomarkersPLoS ONE 2014; 9(4): e93046 doi: 10.1371/journal.pone.0093046
18
Sheng Pan, Teresa A Brentnall, Ru Chen. Glycoproteins and glycoproteomics in pancreatic cancerWorld Journal of Gastroenterology 2016; 22(42): 9288-9299 doi: 10.3748/wjg.v22.i42.9288
19
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinomaOncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
20
Danian Tong, Yujia Zhou, Wei Chen, Yang Deng, Lei Li, Zhenyi Jia, Dachuan Qi. T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancerMolecular Biology Reports 2012; 39(11): 9941 doi: 10.1007/s11033-012-1862-y
21
Takeo Kawahara, Naoe Hotta, Yukiko Ozawa, Seiichi Kato, Keiko Kano, Yukihiro Yokoyama, Masato Nagino, Takashi Takahashi, Kiyoshi Yanagisawa, Martin Fernandez-Zapico. Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion ComplexPLoS ONE 2013; 8(12): e79654 doi: 10.1371/journal.pone.0079654
22
Ai-hua Zhang, Hui Sun, Guang-li Yan, Ying Han, Xi-jun Wang. Serum Proteomics in Biomedical Research: A Systematic ReviewApplied Biochemistry and Biotechnology 2013; 170(4): 774 doi: 10.1007/s12010-013-0238-7
23
Katelyn F. Flick, Michele T. Yip-Schneider, Christopher M. Sublette, Rachel E. Simpson, Cameron L. Colgate, Huangbing Wu, Mazhar Soufi, John M. Dewitt, Amber L. Mosley, Eugene P. Ceppa, Jianjun Zhang, C. Max Schmidt. A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm DysplasiaPancreas 2020; 49(8): 1044 doi: 10.1097/MPA.0000000000001628
24
Lucie Habartová, Bohuš Bunganič, Michal Tatarkovič, Miroslav Zavoral, Jana Vondroušová, Kamila Syslová, Vladimír Setnička. Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancerChirality 2018; 30(5): 581 doi: 10.1002/chir.22834
25
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados, Octavio Caba. Proteomic biomarkers in body fluids associated with pancreatic cancerOncotarget 2018; 9(23): 16573 doi: 10.18632/oncotarget.24654
26
Krissi Danielsson, Daniel Ansari, Roland Andersson. Personalizing pancreatic cancer medicine: what are the challenges?Personalized Medicine 2013; 10(1): 45 doi: 10.2217/pme.12.111